112 related articles for article (PubMed ID: 17984310)
21. Cyclophosphamide in scleroderma lung disease.
Andreu JL; Silva L
N Engl J Med; 2006 Sep; 355(11):1173; author reply 1174. PubMed ID: 16977700
[No Abstract] [Full Text] [Related]
22. Cyclophosphamide in scleroderma lung disease.
Kuschner WG
N Engl J Med; 2006 Sep; 355(11):1173; author reply 1174. PubMed ID: 16971726
[No Abstract] [Full Text] [Related]
23. Cyclophosphamide versus placebo in scleroderma lung disease.
Tashkin DP; Elashoff R; Clements PJ; Goldin J; Roth MD; Furst DE; Arriola E; Silver R; Strange C; Bolster M; Seibold JR; Riley DJ; Hsu VM; Varga J; Schraufnagel DE; Theodore A; Simms R; Wise R; Wigley F; White B; Steen V; Read C; Mayes M; Parsley E; Mubarak K; Connolly MK; Golden J; Olman M; Fessler B; Rothfield N; Metersky M;
N Engl J Med; 2006 Jun; 354(25):2655-66. PubMed ID: 16790698
[TBL] [Abstract][Full Text] [Related]
24. A pilot study of intermittent intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung disease.
Várai G; Earle L; Jimenez SA; Steiner RM; Varga J
J Rheumatol; 1998 Jul; 25(7):1325-9. PubMed ID: 9676764
[TBL] [Abstract][Full Text] [Related]
25. [Advances in the treatment of scleroderma].
Marquet R; Vilardell M
Med Clin (Barc); 1984 Jun; 83(2):74-7. PubMed ID: 6147448
[No Abstract] [Full Text] [Related]
26. Serial changes in scleroderma and idiopathic interstitial lung disease.
Colp CR; Riker J; Williams MH
Arch Intern Med; 1973 Oct; 132(4):506-15. PubMed ID: 4742404
[No Abstract] [Full Text] [Related]
27. Cyclophosphamide for scleroderma lung disease.
Martinez FJ; McCune WJ
N Engl J Med; 2006 Jun; 354(25):2707-9. PubMed ID: 16790705
[No Abstract] [Full Text] [Related]
28. Fixed drug eruption induced by cyclophosphamide.
Sakurai K; Otsuka A; Miyachi Y; Kabashima K
Eur J Dermatol; 2012; 22(3):401-2. PubMed ID: 22378104
[No Abstract] [Full Text] [Related]
29. [So-called immunosuppressive cytotoxic medication in acute disseminated lupus erythematosus and scleroderma].
Thivolet J; Perrot H
Bull Soc Fr Dermatol Syphiligr; 1970; 77(3):412-4. PubMed ID: 5510738
[No Abstract] [Full Text] [Related]
30. [Comparative study between oral azathioprine and intravenous cyclophosphamide pulses in the treatment of idiopathic pulmonary fibrosis].
Roig V; Herrero A; Arroyo-Cózar M; Vielba D; Juarros S; Macías E
Arch Bronconeumol; 2010 Jan; 46(1):15-9. PubMed ID: 19879035
[TBL] [Abstract][Full Text] [Related]
31. Rituximab for systemic sclerosis: arrest of pulmonary disease progression in five cases. Results of a lower dosage and shorter interval regimen.
Moazedi-Fuerst FC; Kielhauser SM; Brickmann K; Hermann J; Lutfi A; Meilinger M; Brezinschek HP; Graninger WB
Scand J Rheumatol; 2014; 43(3):257-8. PubMed ID: 24611681
[No Abstract] [Full Text] [Related]
32. [Treatment of idiopathic pulmonary fibrosis].
Dury S
Rev Mal Respir; 2006 Apr; 23(2 Pt 2):5S87-5S91. PubMed ID: 16788517
[No Abstract] [Full Text] [Related]
33. The efficacy of oral cyclophosphamide plus prednisolone in early diffuse systemic sclerosis.
Calguneri M; Apras S; Ozbalkan Z; Ertenli I; Kiraz S; Ozturk MA; Celik I
Clin Rheumatol; 2003 Oct; 22(4-5):289-94. PubMed ID: 14579158
[TBL] [Abstract][Full Text] [Related]
34. D-penicillamine treatment of lung involvement in patients with systemic sclerosis (scleroderma).
Medsger TA
Arthritis Rheum; 1987 Jul; 30(7):832-4. PubMed ID: 3304300
[No Abstract] [Full Text] [Related]
35. Cyclophosphamide: similarities and differences in the treatment of SSc and SLE.
Bruni C; Shirai Y; Kuwana M; Matucci-Cerinic M
Lupus; 2019 Apr; 28(5):571-574. PubMed ID: 30961417
[No Abstract] [Full Text] [Related]
36. Hematopoietic stem cell transplantation for systemic sclerosis with rapid improvement in skin scores: is neoangiogenesis occurring?
Burt RK; Oyama Y; Traynor A; Quigley K; Brush M; Rodriguez J; Barr WG
Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S65-7. PubMed ID: 12931246
[TBL] [Abstract][Full Text] [Related]
37. Systemic administration of 2-chloro-2'-deoxyadenosine (2-CdA) in patients with systemic scleroderma.
Majewski S; Skopińska M; Błaszczyk M; Ryba M; Grieb P; Chorzelski T; Jabłońska S
Arch Immunol Ther Exp (Warsz); 1994; 42(1):33-4. PubMed ID: 7503631
[TBL] [Abstract][Full Text] [Related]
38. [Case report and discussion of a patient with polymyositis, fibrosing alveolitis and scleroderma-like involvement of the right hand].
Wunderlin B; Knüsel O; Kummer H
Z Rheumatol; 1996; 55(3):188-97. PubMed ID: 8768149
[TBL] [Abstract][Full Text] [Related]
39. Interstitial lung disease associated with systemic sclerosis: what is the evidence for efficacy of cyclophosphamide?
Bérezné A; Valeyre D; Ranque B; Guillevin L; Mouthon L
Ann N Y Acad Sci; 2007 Sep; 1110():271-84. PubMed ID: 17911442
[TBL] [Abstract][Full Text] [Related]
40. The efficacy of treatment for systemic sclerosis interstitial lung disease: results from a meta-analysis.
Broad K; Pope JE
Med Sci Monit; 2010 Sep; 16(9):RA187-90. PubMed ID: 20802426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
